Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
Holding LFMD?
Track your performance easily
LFMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.99 - $12.88
Previous Close$5.42
Volume481.33K
Average Volume (3M)541.40K
Market Cap
$240.82M
Enterprise Value$230.12M
Total Cash (Recent Filing)$37.60M
Total Debt (Recent Filing)$25.14M
Price to Earnings (P/E)―
Beta2.32
Next Earnings
Apr 08, 2025EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding43,312,117
10 Day Avg. Volume1,010,933
30 Day Avg. Volume541,399
Standard Deviation0.48
R-Squared0.02
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)-30.11
Price to Sales (P/S)1.25
Price to Cash Flow (P/CF)9.70
P/FCF Ratio18.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.19
Enterprise Value/Gross Profit1.72
Enterprise Value/Ebitda-23.15
Forecast
1Y Price Target
$12.00Price Target Upside110.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
LifeMD News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceLFMD delivered an impressive top-line beat of $44.1M, beating previously announced guidance of $42M-$43M.
Insurance And AccessibilityLifeMD's virtual primary care platform will now accept commercial health insurance for its primary care services, significantly lowering out-of-pocket costs for patients.
Market DemandThe massive market demand for lower cost solutions for GLP-1s or compounded versions for them is high, benefiting both LifeMD and Hims.
Bears Say
Business HealthWorkSimpli missteps during the quarter keep overall business health in the penalty box.
Subscriber BaseWorkSimpli active subscribers declined to 158.5k due to softness in customer acquisition based on an increase in ad costs, alongside executional missteps.
Subscriber GrowthWorkSimpli active subscribers declined 8% YoY, driven by softness in 1H24 customer acquisition.
---
Ownership Overview
4.66% Insiders
8.03% Mutual Funds
12.07% Other Institutional Investors
66.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LFMD FAQ
What was LifeMD’s price range in the past 12 months?
LifeMD lowest stock price was $3.99 and its highest was $12.88 in the past 12 months.
What is LifeMD’s market cap?
Currently, no data Available
When is LifeMD’s upcoming earnings report date?
LifeMD’s upcoming earnings report date is Apr 08, 2025 which is in 137 days.
How were LifeMD’s earnings last quarter?
LifeMD released its earnings results on Nov 07, 2024. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.118 by -$0.022.
Is LifeMD overvalued?
According to Wall Street analysts LifeMD’s price is currently Undervalued.
Does LifeMD pay dividends?
LifeMD does not currently pay dividends.
What is LifeMD’s EPS estimate?
LifeMD’s EPS estimate is -$0.05.
How many shares outstanding does LifeMD have?
LifeMD has 43,312,120 shares outstanding.
What happened to LifeMD’s price movement after its last earnings report?
LifeMD reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.118. Following the earnings report the stock price went up 14.035%.
Which hedge fund is a major shareholder of LifeMD?
Among the largest hedge funds holding LifeMD’s share is Royce & Associates LLC. It holds LifeMD’s shares valued at 5M.
---
LifeMD Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (110.90% Upside)
$12.00 (110.90% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 352.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $14.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
78.32%
Trailing 12-Months
Company Description
LifeMD
Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.
---
LFMD Company Deck
---
LFMD Earnings Call
Q3 2024
0:00 / 0:00
---
LFMD Stock 12 Month Forecast
Average Price Target
$12.00
▲(110.90% Upside)
Technical Analysis
Best Analysts Covering LFMD
1 Year
1 Year Success Rate
10/30 ratings generated profit
1 Year Average Return
+19.21%
reiterated a buy rating last month
Copying David Larsen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +19.21% per trade.
---